REFERENCES
- Brewer C. Ultra rapid antagonist precipitated opiate detoxification under general anesthesia or sedation. Addiction Biology 1997; 2: 291–302
- Brewer C. Opiate detoxification under anaesthesia. BMJ 1998; 316: 1983–1984
- Simon D L. Rapid opioid detoxification using opioid antagonists: History, theory and state of the art. J Addict Dis 1997; 16: 103–122
- Loimer N, Schmid R W, Presslich O, Lenz K. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatr Res 1989; 23: 81–86
- Loimer N, Lenz K, Schmid R, Presslich O. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. Am J Psychiatry 1991; 148: 933–935
- Newman M K, Berris J M. Artificial hibernation therapy. Arch Phys Ther 1941; 22: 161–170
- Resnick R B, Fink M, Freedman A M. Cyclazocine treatment of opiate dependence: A progress report. Compr Psychiatry 1971; 12: 491–502
- Resnick R B, Kestenbaum R S. Washton A, Poole D. Naloxone-precipitated withdrawal: A method for rapid induction onto naltrexone. Clin Pharmacol Ther 1977; 21: 409–413
- San L, Puig M, Bulbena A, Farre M. High risk of ultrashort noninvasive opiate detoxification. Am J Psychiatry 1995; 152: 956
- Mayor S. Specialists criticise treatment for heroin addiction. BMJ 1997; 314: 1365
- Strang J, Bearn J, Gossop M. Opiate detoxification under anaesthesia. BMJ 1997; 315: 1249–1250
- Legarda J J, Gossop M. A 24 h inpatient detoxification treatment for heroin addicts: A preliminary investigation. Drug Alcohol Depend 1994; 35: 91–93
- Judson B A, Himmelberger D U, Goldstein A. The naloxone test for opiate dependence. Clin Pharmacol Ther 1980; 27: 492–501
- Kolb L, Himmelsbach C K. Clinical studies of drug addiction III. A critical review of withdrawal treatments with method of evaluating abstinence syndromes. Am J Psychiatry 1938; 94: 759–797
- Pfab R, Hirtl C, Hibler A, Felgenhauer N, Chlistalla J, Zilker Th. Der Antagonist-induzierte Narkose-gestiitzte Opiat-Schnellentzug (AINOS). Münchner Med Wochenschrift 1996; 138: 781–786
- O'Connor P G, Kosten T R. Rapid and ultrarapid opioid detoxification techniques. JAMA 1998; 279: 229–234
- Röjdmark S, Adner N, Andersson D, Austern J, Lamminpaa K. Prolactin and thyrotropin responses to thyrotropin-releasing hormone and metoclopramide in men with chronic alcoholism. J Clin Endocrinol Metab 1984; 59: 595–600
- Brabant G, Prank K, Hoang-Vu C, Hesch R D, von zur Muhlen A. Hypothalamic regulation of pulsatile thyrotopin secretion. J Clin Endocrinol Metab 1991; 72: 145–150
- Gonzalez J P, Brogden R N. Naltrexone. A Review of its pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988; 35: 192–213
- Brewer C, Razae H, Bailey C. Opioid withdrawal and naltrexone induction in 48–72 hours with minimal dropout, using a modification of the naltrexoneclonidine technique. Brit J Psychiatry 1988; 153: 340–343
- Van Tilborg K A, Rabelink T J, Koomans H A. Naloxone inhibits renal hemodynamic effect of head-out immersion in humans. Kidney Int 1995; 48: 860–865
- DiBona G F, Jones S Y. Role of endogenous peripheral opioid mechanisms in renal function. J Am Soc Nephrol 1994; 4: 1792–1797
- Hill S A, Quinn K, Shelly M P, Park G R. Reversible renal failure following opioid administration. Anaesthesia 1991; 46: 938–939
- Brimacombe J, Archdeacon S, Newell S, Martin J. Two cases of naloxone-induced pulmonary oedema-the possible use of phentolamine in management. Anaesth Intensive Care 1991; 19: 578–580
- Olsen K S. Naloxone administration and laryngospasm followed by pulmonary edema. Intensive Care Med 1990; 16: 340–341
- Wride S R, Smith R E, Courtney P G. A fatal case of pulmonary edema in a healthy young male following naloxone administration. Anaesth Intensive Care 1989; 17: 374–377